Tuesday, 13 August 2024 07:00 AM
Company Update
Market Survey on Phytopathological Disease Diagnostics Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment.
NEWARK, DE / ACCESSWIRE / August 13, 2024 / The global phytopathological disease diagnostics market is estimated to reach USD 105.2 million in 2024. Projecting forward, the market is expected to reach USD 163.4 million by 2034, reflecting a steady CAGR of 4.5% during the forecast. The industry is primarily driven by the increasing global demand for food security and sustainable agriculture practices. With rising concerns about crop diseases and their impact on yield and quality, there is a growing need for accurate and efficient diagnostic tools. Technological advancements, such as AI-driven image analysis and portable DNA sequencers, are driving innovation in the industry, enabling faster and more precise detection of plant pathogens.
The industry faces several restraints that hinder its growth and adoption. Regulatory hurdles and licensing requirements for diagnostic products and technologies vary across regions, posing challenges for companies seeking to enter new markets. Additionally, the high cost of advanced diagnostic equipment and the lack of infrastructure and trained personnel in some regions limit access to diagnostic services, particularly in developing countries.
The increasing adoption of precision agriculture practices and integrated pest management approaches create a favorable environment for diagnostic companies to offer comprehensive disease management solutions. Furthermore, the rising demand for organic and sustainably produced food products drives investment in innovative diagnostic technologies that support environmentally friendly farming practices, presenting new avenues for market growth and differentiation.
The phytopathological disease diagnostics industry is witnessing several notable developments that are shaping its future trajectory. One of the latest trends is the integration of digital technologies and data analytics into diagnostic platforms, enabling real-time monitoring of crop health and disease outbreaks. Additionally, there is a growing emphasis on the development of rapid and point-of-care diagnostic tools that provide on-site detection and immediate results, allowing for timely intervention and disease management. Furthermore, advancements in gene editing technologies, such as CRISPR-Cas9, offer new opportunities for developing disease-resistant crop varieties, reducing the reliance on chemical pesticides and enhancing sustainable agriculture practices.
What Are The Factors Driving Phytopathological Disease Diagnostics Market?
"Growing Food Insecurity Concerns Due to Persistent Threat of Plant Disease Pandemics Triggering Market Growth"
The emergence of various crop diseases has become an imminent threat to food security worldwide. According to the Food and Agriculture Organization (FAO) of United States, plant diseases cost the global economy around $220 billion each year. This is prompting government and farmers to adopt better plant disease management approaches.
Presence of phytopathogens such as fungal and bacterial species causes enormous losses in both quality and quantity of crop yields. Precise detection and identification of these species therefore becomes essential for facilitating effective diseases management.
Advances in diagnostic research have paved way for the development of novel plant diseases detection techniques such as PCR based assays, ELSIA and QCMI. These tests are utilized for the proper detection of various plant diseases. Once the disease is detected, a specific treatment approach can be initiated easily.
Increasing prevalence of plant diseases along with growing food insecurity is anticipated to boost the growth of phytopathological disease diagnostics market during the assessment period.
"Strategic partnerships with agricultural stakeholders, including farmers, agronomists, and research institutions, can facilitate the development and implementation of targeted diagnostic strategies tailored to specific crops and regions." Says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).
Full Report Now: https://www.futuremarketinsights.com/reports/phytopathological-disease-diagnostics-market
Key Takeaways from the Phytopathological Disease Diagnostics Market Study:
Serological tests emerge as the dominant segment in the market, capturing a significant market share of 58.1% in 2024.
The diagnostic kits maintain their dominance, holding a substantial market share of 43.4% in 2024.
The United States maintains its leadership position in the phytopathological disease diagnostics market, projecting a consistent 3.9% CAGR through 2034.
Conversely, the United Kingdom anticipates a more measured approach to growth, with a projected CAGR of 2.2% by 2034.
India's remarkable growth potential in the market is evident, with a projected CAGR of 6% through 2034.
Serological tests lead the market with a notable share of 58.1% in 2024, focusing on the detection of antibodies in response to specific pathogens.
Diagnostic kits stand out as the most dominant product category, boasting a market share of 43.4% in 2024.
Why is the U.K. Considered as a Lucrative Phytopathological Disease Diagnostics Market?
"Increasing Botanical Research Favoring Growth of Phytopathological Disease Diagnostics Market in the U.K."
As per FMI, the U.K. will continue to remain one of the lucrative markets for phythopathological disease diagnostics owing to the favorable regulatory policies, continuous adoption of advanced diagnostic technology and presence of leading market players
During the last few decades, a number of new plant diseases, plant pests and invasive alien species have emerged as significant threat to the plant species in England. This has put phythopathological disease diagnostic technologies to the forefront.
Plant and crop management has become a top priority for government and other private agricultural organizations. Various diagnostic techniques such as PCR based assays and ELISA are being adopted to detect the presence of pathogens such as ralstonia solanacerum and phytophthora ramorum in plants. This is providing impetus to the growth of phytopathological disease diagnostics market in the country.
Subsequently, various researches are being conducted across multiple laboratories in the U.K. for developing better plant treatments and diagnostic approaches. The main aim is to develop plant disease-resilient and plant pest resilient species.
Competition Outlook of the Phytopathological Disease Diagnostics Market:
The phytopathological disease diagnostics industry is experiencing a period of rapid evolution driven by technological advancements and growing global concerns about food security. While established diagnostic methods like PCR and ELISA continue to dominate the market, emerging technologies such as AI-driven image analysis and portable DNA sequencers are reshaping the landscape. This proliferation of innovative diagnostic tools offers both opportunities and challenges for industry players. Companies that can effectively harness these technologies to deliver accurate, rapid, and cost-effective diagnostic solutions stand to gain a competitive edge in the market.
The industry faces competition not only from traditional diagnostic companies but also from research institutions and agricultural biotechnology firms. As demand for precision agriculture and sustainable farming practices grows, diagnostic companies must differentiate themselves by offering comprehensive disease management solutions that integrate diagnostics with actionable insights and agronomic recommendations. Collaboration between industry players, research organizations, and agricultural stakeholders will be essential to drive innovation and address the evolving needs of the agriculture sector.
Recent Developments:
Michigan State University's Plant & Pest Diagnostics, in conjunction with MDARD's Plant Pathology Laboratory, continue their aim to raise agricultural standards by developing cutting-edge diagnostic solutions.
With the introduction of the Thrips Spot Viruses ImmunoComb, Agdia Inc., a US company with its headquarters in Wilmington, Delaware, revolutionizes plant virus identification by providing growers all over the world with a portable and effective instrument.
Abingdon Health plc, situated in York, United Kingdom, has partnered with Morrama Ltd to form Eco-Flo Innovations Ltd, which will pioneer sustainable lateral flow test housings for eco-conscious diagnostics.
Planet Labs PBC, situated in San Francisco, California (United States), has expanded its data analytics capabilities with the purchase of Sinergise, heralding a new age of accuracy in plant disease identification and agricultural surveillance.
Leading Companies in the Phytopathological Disease Diagnostics Market:
ThermoFischer Scientific
Clear Detections B.V
Merck KGaA
Agdia, Inc.
Qualiplante SAS
A Old Source of - Full Report
Key Segments of Phytopathological Disease Diagnostics Market Report:
By Product Type:
Product segments in the industry include kits such as ELISA kits, DNA-based diagnostics kits, and protein-based diagnostics kits. Additionally, there are lateral flow devices, DNA/RNA probes, and accessories and other consumables. software and cloud databases are also part of this category.
By Test Type:
Test segments encompass molecular tests, which consist of PCR-based assays, PCR & RT-PCR, and multiplex PCR. isothermal amplification assays, microarray assays, NASBA, and LAMP assays are also included. serological tests, like ELSIA, TBIA, and QCMI, along with tests using electronic technology, complete this category.
By Sample Type:
Sample types for testing include seeds, grains, plants, trees, and fruits.
By End User:
End users of these products and tests can be agricultural laboratories, academic and research institutes, food processing laboratories, contract research organizations, and others who utilize these tools and technologies for various purposes.
By Region:
The industry is segmented by regions which are North America, Latin America, Europe, East Asia, South Asia and Pacific, and the Middle East and Africa.
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Have a Look at the Related Report from the Phytopathological Disease Diagnostics Market:
The global poultry diagnostics market demand is subjected to record a CAGR of 10.5%. The market revenue is likely to be valued at US$ 590 million in 2023 and exhibit a revenue growth of US$ 1.6 billion by 2033.
The rare disease clinical trials market size is projected to be valued at US$ 12,566.14 million in 2023 and is expected to rise to US$ 31,715.25 million by 2033. The sales of rare disease clinical trials are expected to record a significant CAGR of 9.7% during the forecast period.
The global chlamydia diagnostics market garnered a market value of US$ 1.17 Billion in 2022 and is expected to accumulate a market value of US$ 3.69 Billion by registering a CAGR of 11% in the forecast period 2023 to 2033.
The global neurodegenerative disease market, from an estimated valuation of USD 52 billion in 2024 to a forecasted USD 102.4 billion by 2034 at a CAGR of 7%, heralds a significant shift in the healthcare landscape.
The market size for infectious disease diagnostics market is expected to grow at a steady pace, reaching USD 21.5 billion in 2024. It is estimated that this positive trend will continue, with the market reaching USD 43.2 billion by 2034. Based on these estimates, a CAGR of 7.2% is expected over the next decade.
The global autoimmune disease therapeutics market is likely to be valued at US$ 71,466.47 million in 2023 and is predicted to secure a moderate-paced CAGR of 5.6% during the forecast period. The market is expected to grow at a value of US$ 123,507.30 million by 2033. A historical CAGR of 3.6% has been recorded during the analysis by Future Market Insights.
The global Wilson's disease diagnostics market is expected to garner a market value of US$ 611.16 Million in 2023 and is expected to accumulate a market value of US$ 896 Million by registering a CAGR of 3.9% in the forecast period 2023 to 2033.
The shrimp disease diagnostics market is anticipated to record a CAGR of 11.3% during the forecast period, up from US$ 174.91 Mn in 2021 to reach a valuation of US$ 567.88 Mn by 2032.
The global veterinary infectious disease diagnostics market is estimated to reach a valuation of US$ 1.9 billion in 2023. As per Future Market Insights (FMI) analysis, the veterinary infectious disease diagnostics market size is expected to surpass US$ 4.9 billion in the next decade. Between 2023 and 2033, the market has been forecast to register a 10.1% CAGR.
The global cancer diagnostics market is projected to expand steadily at a CAGR of 8.5% value, from 2023 to 2033. In the year 2023, the market size is projected to expand and gain a global market valuation of US$ 55.71 billion. Considering this increasing growth and demand in the global market, the market is expected to reach US$ 126 billion by 2033.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
SOURCE: Future Market Insights, Inc.